Savior LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Savior LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,500
+22.0%
3,5000.0%0.07%
+108.6%
Q2 2023$8,610
+8.8%
3,5000.0%0.04%
+400.0%
Q1 2023$7,910
-35.2%
3,5000.0%0.01%
-36.4%
Q4 2022$12,215
-90.6%
3,5000.0%0.01%
-90.9%
Q3 2022$130,000
+97.0%
3,5000.0%0.12%
+98.4%
Q2 2022$66,000
-27.5%
3,5000.0%0.06%
-10.3%
Q1 2022$91,000
+19.7%
3,5000.0%0.07%
+2166.7%
Q4 2021$76,000
-17.4%
3,5000.0%0.00%
-96.8%
Q3 2021$92,000
-17.9%
3,5000.0%0.09%0.0%
Q2 2021$112,000
-8.9%
3,5000.0%0.09%
-24.2%
Q1 2021$123,0003,5000.12%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders